Keywords
Last Name
Institution

Funding Agency: Windtree Therapeutics, Inc.
Title: 205091 Lucinactant for inhalation in preterm neonates 26-32 weeks gestational age with rds
Award Number: 03-CL-1202
Start Date: 2016-06-24


Collapse Overview 
Collapse researcher role of